Ballydel Technologies
1 known investors
Ballydel Technologies develops novel materials and manufacturing processes for use in pharmaceutical, defense, energy, and consumer goods applications.
Investors · 1
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase IISTTR | 2023 | $1.2M |
| U.S. ArmyArmy | Phase ISTTR | 2022 | $173K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase I | 2022 | $167.4K |
| U.S. Air ForceAir Force | Phase ISTTR | 2022 | $150K |
| National Science Foundation | Phase I | 2021 | $256K |
| NASA | Phase I | 2021 | $124.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Ballydel Technologies do?
- Ballydel Technologies develops novel materials and manufacturing processes for use in pharmaceutical, defense, energy, and consumer goods applications.
- Who are Ballydel Technologies's investors?
- Ballydel Technologies's investors include The Innovation Space.